Journal of Pharmacogenomics & Pharmacoproteomics

Transcriptomic Signatures: Interpreting Gene Expression Patterns for Disease Classification and Therapeutic Response

Clara Mendes ^* Department of Molecular Biology, University of São Paulo, São Paulo, Brazil
^*Correspondence: Clara Mendes, Department of Molecular Biology, University of São Paulo, São Paulo, Brazil, Email:

Received: 29-Aug-2025 , Manuscript No. JPP-25-32628; Editor assigned: 01-Sep-2025 , Pre QC No. JPP-25-32628; Reviewed: 15-Sep-2025 , QC No. JPP-25-32628; Revised: 22-Sep-2025 , Manuscript No. JPP-25-32628; Published: 29-Sep-2025 , DOI: 10.35248/2153-0645.25.16.151

Description

Transcriptomic signatures are defined patterns of Ribonucleic Acid (RNA) expression that reflect the biological condition of cells, tissues, or organisms. Because RNA levels change in response to developmental signals, disease processes, environmental conditions and medicines, transcriptomic profiles can provide valuable information about cellular activity. A signature may consist of a small group of genes or a larger collection of transcripts whose combined expression pattern is associated with a particular biological state, disease category, treatment response, or clinical outcome. The transcriptome represents the collection of RNA molecules produced by cells under particular conditions. Messenger RNA carries information required for protein production, while non-coding RNAs participate in gene regulation, RNA processing, cellular communication and other functions. The amount of individual RNA molecules can vary substantially between tissues and can change according to cellular signals. Measuring these changes allows scientists to characterize molecular states that may not be apparent from clinical observations alone.

Transcriptomic signatures are commonly generated by measuring RNA abundance across many genes. RNA sequencing is widely used for this purpose because it can identify and quantify numerous transcripts within a biological sample. Other platforms, including microarrays and targeted RNA panels, can also provide expression profiles. The selected method depends on the number of genes being examined, sample characteristics, available equipment and the intended application. A transcriptomic signature may be associated with a specific disease. For example, cancer cells can display gene expression patterns that differ from those found in normal tissues. Differences in genes involved in cell division, Deoxyribonucleic Acid (DNA) repair, metabolism, immune signaling and cell death can produce recognizable molecular profiles. Such patterns can assist with classification of disease subtypes and provide information about biological activity within affected tissues.

Transcriptomic signatures can also describe immune activity. Genes involved in cytokine signaling, antigen presentation, immune-cell activation and inflammatory pathways may show altered expression during infection or chronic inflammation. By examining groups of related genes rather than relying on one transcript, a signature can provide a broader indication of immune status. This approach can be useful when evaluating conditions in which immune activity changes over time. Drug response is another important application. Medicines can alter gene expression within target cells. Some treatments activate specific signaling pathways, while others suppress genes associated with proliferation or inflammatory activity. Comparing transcriptomic profiles before and after treatment can identify expression changes associated with pharmacological activity. Distinct signatures may also help explain why some patients respond well while others show limited benefit.

Transcriptomic signatures have particular relevance to cancer pharmacology. Tumors can contain molecularly distinct populations of cells even when they originate from the same tissue. Gene expression patterns can provide information about proliferation, immune-cell infiltration, DNA repair activity and signaling pathways. Certain expression profiles may be associated with sensitivity or resistance to particular treatment classes. This information can complement genomic mutation data when evaluating therapeutic options. RNA expression can also change during the development of treatment resistance. A cancer cell may activate alternative signaling pathways, increase expression of drug transport proteins, or alter genes involved in cell survival. These changes can occur alongside genetic alterations or independently of them. A transcriptomic signature may therefore provide information about the molecular state of resistant cells and help identify pathways that require additional therapeutic attention.

Single-cell transcriptomics provides a more detailed approach by measuring RNA expression within individual cells. Traditional tissue-level measurements combine RNA from many cell types, which can hide differences between distinct populations. Single-cell analysis can separate immune cells, tumor cells, stromal cells and other populations. This allows expression signatures to be assigned to specific cell groups rather than to an entire tissue sample. Spatial transcriptomics adds information about the location of RNA molecules within tissues. Gene expression can be linked to particular regions or cellular neighborhoods while preserving information about tissue organization. This can be useful for examining tumors, brain tissue, inflammatory lesions and other complex biological structures where location influences cellular behavior.

Bioinformatics plays an important role in generating and interpreting transcriptomic signatures. Large RNA datasets require normalization, quality assessment, statistical analysis and computational classification. Algorithms can identify groups of genes that change together and can construct expression-based scores. Machine-learning methods can also classify samples according to predefined biological or clinical categories. Appropriate validation is required to determine whether a signature performs consistently in independent datasets. Sample quality has a major influence on transcriptomic analysis. RNA can degrade during collection, storage, or processing, potentially affecting expression measurements. Tissue composition can also influence results because different samples may contain different proportions of cell types. Factors such as age, medication exposure, disease stage, nutritional status and collection conditions should therefore be considered when interpreting expression patterns.